Sign up to save your podcasts
Or
Share Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab
Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Pashtoon Kasi from City of Hope to discuss the management of side effects associated with key treatments utilized in colorectal cancer, but also in other tumor types.
We dived deep into two important drug classes: Bevacizumab, an anti-VEGF antibody, and the anti-EGFR antibodies, Panitumumab and Cetuximab. Dr. Kasi provided a comprehensive overview of these targeted therapies, their mechanisms of action, and the common side effects that patients may experience.
Key topics covered in this episode included:
• Overview of Bevacizumab and its side effects, including hypertension, proteinuria, and risk of bleeding.
• Clinical pearls for managing side effects associated with Bevacizumab.
• Discussion on the skin toxicities, nail changes, and electrolyte imbalances related to Panitumumab and Cetuximab.
• The importance of preemptive strategies in managing skin rashes and other side effects.
• Insights into infusion reactions with Cetuximab and considerations for patient safety.
Join us for this informative discussion that aims to enhance your understanding of these critical therapies and improve patient outcomes.
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
Don't forget to check out our other episodes in the Tox Check series, where we explore antibody-drug conjugates and CAR T therapies.
Subscribe to our channel for more insights on oncology treatments and patient care!
View all episodes
By Oncology Brothers
4.8
3939 ratings
Welcome to another episode of the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Pashtoon Kasi from City of Hope to discuss the management of side effects associated with key treatments utilized in colorectal cancer, but also in other tumor types.
We dived deep into two important drug classes: Bevacizumab, an anti-VEGF antibody, and the anti-EGFR antibodies, Panitumumab and Cetuximab. Dr. Kasi provided a comprehensive overview of these targeted therapies, their mechanisms of action, and the common side effects that patients may experience.
Key topics covered in this episode included:
• Overview of Bevacizumab and its side effects, including hypertension, proteinuria, and risk of bleeding.
• Clinical pearls for managing side effects associated with Bevacizumab.
• Discussion on the skin toxicities, nail changes, and electrolyte imbalances related to Panitumumab and Cetuximab.
• The importance of preemptive strategies in managing skin rashes and other side effects.
• Insights into infusion reactions with Cetuximab and considerations for patient safety.
Join us for this informative discussion that aims to enhance your understanding of these critical therapies and improve patient outcomes.
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
Don't forget to check out our other episodes in the Tox Check series, where we explore antibody-drug conjugates and CAR T therapies.
Subscribe to our channel for more insights on oncology treatments and patient care!
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
322 Listeners
Journal of Clinical Oncology (JCO) Podcast
42 Listeners
Research To Practice | Oncology Videos
111 Listeners
JAMA Clinical Reviews
504 Listeners
ASCO Daily News
60 Listeners
Core IM | Internal Medicine Podcast
1,114 Listeners
OncoPharm
182 Listeners
ASCO Guidelines
45 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
360 Listeners
Lung Cancer Considered
28 Listeners
The Passive Income MD Podcast
277 Listeners
Oncology Today with Dr Neil Love
60 Listeners
Two Onc Docs
181 Listeners
Blood Cancer Talks
48 Listeners